Plichta, K. A., Graves, S. A., & Buatti, J. M. (2021). Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer. MDPI AG.
Cita Chicago Style (17a ed.)Plichta, Kristin A., Stephen A. Graves, y John M. Buatti. Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer. MDPI AG, 2021.
Cita MLA (8a ed.)Plichta, Kristin A., et al. Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer. MDPI AG, 2021.
Precaución: Estas citas no son 100% exactas.